JP2021521280A - 弾性線維分解を治療するための組成物及び方法 - Google Patents

弾性線維分解を治療するための組成物及び方法 Download PDF

Info

Publication number
JP2021521280A
JP2021521280A JP2021505625A JP2021505625A JP2021521280A JP 2021521280 A JP2021521280 A JP 2021521280A JP 2021505625 A JP2021505625 A JP 2021505625A JP 2021505625 A JP2021505625 A JP 2021505625A JP 2021521280 A JP2021521280 A JP 2021521280A
Authority
JP
Japan
Prior art keywords
acid
kda
pharmaceutical composition
composition according
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021505625A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021521280A5 (enExample
Inventor
カントール，ジェローム，オー．
トゥリーノ，ジェラード，エム．
Original Assignee
マトルクス セラピューティクス コーポレーション
マトルクス セラピューティクス コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マトルクス セラピューティクス コーポレーション, マトルクス セラピューティクス コーポレーション filed Critical マトルクス セラピューティクス コーポレーション
Publication of JP2021521280A publication Critical patent/JP2021521280A/ja
Publication of JP2021521280A5 publication Critical patent/JP2021521280A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021505625A 2018-04-12 2019-04-12 弾性線維分解を治療するための組成物及び方法 Pending JP2021521280A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862656654P 2018-04-12 2018-04-12
US62/656,654 2018-04-12
PCT/US2019/027257 WO2019200274A1 (en) 2018-04-12 2019-04-12 Compositions and methods for treating elastic fiber breakdown

Publications (2)

Publication Number Publication Date
JP2021521280A true JP2021521280A (ja) 2021-08-26
JP2021521280A5 JP2021521280A5 (enExample) 2022-04-22

Family

ID=66323966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505625A Pending JP2021521280A (ja) 2018-04-12 2019-04-12 弾性線維分解を治療するための組成物及び方法

Country Status (4)

Country Link
US (4) US10933084B2 (enExample)
EP (1) EP3773614A1 (enExample)
JP (1) JP2021521280A (enExample)
WO (1) WO2019200274A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021521280A (ja) * 2018-04-12 2021-08-26 マトルクス セラピューティクス コーポレーション 弾性線維分解を治療するための組成物及び方法
CN111265590B (zh) * 2020-01-21 2022-03-01 华熙生物科技股份有限公司 一种用于鼻腔喷雾透明质酸冻干制剂及其制备方法和应用
EP4370144A1 (en) * 2021-07-14 2024-05-22 Redox-co S.r.l. Glutahtione c4 against airway affections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004513071A (ja) * 2000-05-23 2004-04-30 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク 肺の弾性繊維損傷に関連した呼吸器疾患の治療方法
JP2014523435A (ja) * 2011-07-12 2014-09-11 アイホル コーポレーション 粘膜関連疾患を治療および予防するための物質

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA791659B (en) 1978-04-17 1980-04-30 Ici Ltd Process and apparatus for spraying liquid
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
GB8504253D0 (en) 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
DE3815221C2 (de) 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
GB9225098D0 (en) 1992-12-01 1993-01-20 Coffee Ronald A Charged droplet spray mixer
US6105571A (en) 1992-12-22 2000-08-22 Electrosols, Ltd. Dispensing device
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9406171D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9406255D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9410658D0 (en) 1994-05-27 1994-07-13 Electrosols Ltd Dispensing device
IL117473A (en) 1995-03-14 2001-08-26 Siemens Ag Ultrasonic atomizer device with removable precision dosating unit
EP0814861B1 (en) 1995-03-14 2002-06-05 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosing unit
US6251941B1 (en) 1996-04-19 2001-06-26 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the prevention of cancer
US5954047A (en) 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
GEP20043260B (en) 1998-03-16 2004-06-25 Nectar Therapeutics Aerosolized Active Agent Delivery and Device for Realization Thereof
AU2002315330A1 (en) * 2001-06-15 2003-01-02 Exhale Therapeutics, Inc. Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid
EP1811987B1 (en) 2004-11-18 2008-04-02 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Dry powder comprising levothyroxine sodium administered via inhalator
US20150025019A1 (en) * 2013-07-18 2015-01-22 Jerome Owen Cantor Method for Dosage Adjustment of Drugs that Prevent Elastic Fiber Breakdown
JP2021521280A (ja) * 2018-04-12 2021-08-26 マトルクス セラピューティクス コーポレーション 弾性線維分解を治療するための組成物及び方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004513071A (ja) * 2000-05-23 2004-04-30 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク 肺の弾性繊維損傷に関連した呼吸器疾患の治療方法
JP2014523435A (ja) * 2011-07-12 2014-09-11 アイホル コーポレーション 粘膜関連疾患を治療および予防するための物質

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
INTERNATIONAL JOURNAL OF COPD, vol. 12, JPN6023007982, 2017, pages 2747 - 2752, ISSN: 0005211177 *
LUNG, vol. Vol.189(1), JPN6023007981, 2011, pages 51 - 56, ISSN: 0005001188 *

Also Published As

Publication number Publication date
US10933084B2 (en) 2021-03-02
US20210177887A1 (en) 2021-06-17
WO2019200274A1 (en) 2019-10-17
EP3773614A1 (en) 2021-02-17
US20240197770A1 (en) 2024-06-20
US20190314403A1 (en) 2019-10-17
US20260183330A1 (en) 2026-07-02

Similar Documents

Publication Publication Date Title
US20240197770A1 (en) Compositions and methods for treating elastic fiber breakdown
JP6827948B2 (ja) 呼吸器疾患の治療
JP2009529539A (ja) 呼吸器障害を治療するための方法および組成物
JP2001518518A (ja) 分泌性白血球プロテアーゼインヒビターの乾燥粉末薬学的組成物
JP2010502739A (ja) ナトリウムチャネル阻害剤及び浸透圧調節物質を用いた処置による粘膜水和及び粘液クリアランスの改善
TW200817343A (en) Method of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
CA2468344A1 (en) Methods and compositions for treating lesions of the respiratory epithelium
US20240091216A1 (en) Liquid formulations of indacaterol
US20230149643A1 (en) Delivery device and formulation
TW201039833A (en) Novel combinations
BR112015010842B1 (pt) Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
PT2398473E (pt) 5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1- hidroxietil)-8-hidroxiquinolin-2(1h)-ona para o tratamento da função pulmonar
US20220409627A1 (en) Treatment of lower airways disorders
JP2011511801A (ja) 呼吸器系疾患を処置するための方法及び組成物
JP6962990B2 (ja) サルコイドーシスを処置するための１，３−プロパンジスルホン酸またはその薬学的に許容される塩の使用
JP7334983B2 (ja) 肺気腫及びその他の形態のｃｏｐｄの治療のための組成物及び方法
EP4326231A1 (en) Compositions of interleukin-1 receptor antagonist
JP2018127489A (ja) 禁煙のためのβ−アドレナリン作動性インバースアゴニストの使用
WO2021211850A1 (en) Inhalable formulation of a solution containing olodaterol
CA2678920C (en) A medicament for treating chronic obstructive pulmonary disease
CN102369012B (zh) 氧化氘用于治疗病毒性呼吸道疾病的用途
WO2024077042A2 (en) Il-1 receptor antagonist treatment for neutrophilic lung disease
JP2005539058A (ja) 選択的なホスホジエステラーゼ４−阻害物質による非アレルギー性鼻炎の治療
HK1154529A (en) Methods and compositions for treating respiratory disease

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220412

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220412

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230228

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230530

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230831

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231205